Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple routes of palliative chemotherapy for advanced colorectal cancer
ChiCTR-IPR-16007787Phase 4Recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of irinotecan in colorectal cancer (CRC) (2 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoint: Progression-free survival. Started Jan 2016; status: recruiting.
02
Drugs
irinotecan
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR-IPR-16007787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16007787.